First HD multifocal lens for presbyopia and astigmatism

Article

opcon has launched the LENTIS Mplustoric intraocular lens (IOL.

Topcon has launched the LENTIS Mplustoric intraocular lens (IOL, designed to provide astigmatic patients the advanced benefits of Topcon's patented high-definition LENTIS Mplus technology. The company will officially present the lens to the market at the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in Brighton 11-12 November.

The LENTIS Mplustoric combines Topcon's LENTIS Mplus lens with the toric functionalities of the Tplus series. The LENTIS Mplus, which launched in July 2009, has been fitted in over 3,000 patients across the UK. Clinical trials have shown a reported rate of 95% patient satisfaction. Unlike other multifocal IOLs (MIOLs), it has a unique sector-shaped near-vision segment and uses only one transition zone, allowing, claims Topcon, for seamless transition between the near, intermediate and far vision zones and minimal to no risk of halos and glare in patient vision.

Professor Sunil Shah, Consultant Ophthalmologist at the Midland Eye Institute comments: “The LENTIS Mplustoric is simply the best all-in-one lens solution combining presbyopia correction with astigmatism. It is a major technical step forward for the IOL industry as it is the best combination of two highly advanced technologies. This lens has enabled us to better correct the vision of a wider range of patients and the outcomes have so far been remarkable.”

Gloria McCall, Topcon Surgical adds, “Topcon is excited about the launch of the LENTIS Mplustoric and looks forward to presenting it to the UK's top ophthalmologists at the UKISCRS meeting in November. The new lens offers high-definition glass-free vision to patients who would previously not have been suitable for our leading LENTIS Mplus design.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.